Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05725993 · ClinicalTrials.gov registry record

Longitudinal Assessment of Traumatic Microvascular Injury-2

A clinical trial of Traumatic Brain Injury, sponsored by University of Pennsylvania.

Recruiting
Registry status
110
Enrollment target
1
Study location

NCT05725993: Recruiting study of Traumatic Brain Injury, sponsored by University of Pennsylvania.

NCT05725993 is a study of Traumatic Brain Injury that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 110 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05725993, a study of Traumatic Brain Injury, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
110 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn about changes in the brain of patients over the first 3 years following a traumatic brain injury (TBI). The main question it aims to answer are: \- How TBI effect the rate of brain tissue loss compare to healthy brain Participants will give blood samples, complete MRI scans, and neuropsychological assessment measures. Researchers will compare results between healthy control group and TBI group to determine changes in injured brains.

Conditions Studied

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2022-02-01
Est. Completion 2026-03-01

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05725993

The ClinicalTrials.gov registry entry for NCT05725993 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (60% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.

NCT05725993 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05725993 about?

NCT05725993 is a clinical study titled "Longitudinal Assessment of Traumatic Microvascular Injury-2". The goal of this observational study is to learn about changes in the brain of patients over the first 3 years following a traumatic brain injury (TBI). The main question it aims to answer are: \- How TBI effect the rate of brain tissue loss compare to healthy brain Participants will give blood sa...

What is the current status of trial NCT05725993?

This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2022-02-01. Estimated completion is 2026-03-01.

What conditions does trial NCT05725993 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

Who is sponsoring clinical trial NCT05725993?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05725993 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.